![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 17829 |
FusionGeneSummary for ITGA5_MMP9 |
![]() |
Fusion gene information | Fusion gene name: ITGA5_MMP9 | Fusion gene ID: 17829 | Hgene | Tgene | Gene symbol | ITGA5 | MMP9 | Gene ID | 3678 | 4318 |
Gene name | integrin subunit alpha 5 | matrix metallopeptidase 9 | |
Synonyms | CD49e|FNRA|VLA-5|VLA5A | CLG4B|GELB|MANDP2|MMP-9 | |
Cytomap | 12q13.13 | 20q13.12 | |
Type of gene | protein-coding | protein-coding | |
Description | integrin alpha-5CD49 antigen-like family member EITGA5/SLC9B1 fusionfibronectin receptor subunit alphafibronectin receptor, alpha polypeptidefibronectin receptor, alpha subunitintegrin alpha-Fintegrin, alpha 5 (fibronectin receptor, alpha polypepti | matrix metalloproteinase-9macrophage gelatinasematrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)type V collagenase | |
Modification date | 20180522 | 20180527 | |
UniProtAcc | P08648 | P14780 | |
Ensembl transtripts involved in fusion gene | ENST00000293379, ENST00000547744, | ENST00000372330, | |
Fusion gene scores | * DoF score | 3 X 4 X 4=48 | 5 X 4 X 5=100 |
# samples | 4 | 5 | |
** MAII score | log2(4/48*10)=-0.263034405833794 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/100*10)=-1 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: ITGA5 [Title/Abstract] AND MMP9 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation | Tumor suppressor gene involved fusion gene, in-frame but not retained their domain. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ITGA5 | GO:0033627 | cell adhesion mediated by integrin | 12807887|17158881 |
Tgene | MMP9 | GO:0006508 | proteolysis | 2551898|15863497|19022250|24164424 |
Tgene | MMP9 | GO:0034614 | cellular response to reactive oxygen species | 26514923 |
Tgene | MMP9 | GO:0043388 | positive regulation of DNA binding | 22984561 |
Tgene | MMP9 | GO:0071276 | cellular response to cadmium ion | 26514923 |
Tgene | MMP9 | GO:1900122 | positive regulation of receptor binding | 24164424 |
Tgene | MMP9 | GO:2001258 | negative regulation of cation channel activity | 24164424 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | SARC | TCGA-HB-A2OT-01A | ITGA5 | chr12 | 54805618 | - | MMP9 | chr20 | 44642763 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000293379 | ENST00000372330 | ITGA5 | chr12 | 54805618 | - | MMP9 | chr20 | 44642763 | + |
intron-3CDS | ENST00000547744 | ENST00000372330 | ITGA5 | chr12 | 54805618 | - | MMP9 | chr20 | 44642763 | + |
Top |
FusionProtFeatures for ITGA5_MMP9 |
![]() |
Hgene | Tgene |
ITGA5 | MMP9 |
Integrin alpha-5/beta-1 (ITGA5:ITGB1) is a receptor forfibronectin and fibrinogen. It recognizes the sequence R-G-D inits ligands. ITGA5:ITGB1 binds to PLA2G2A via a site (site 2)which is distinct from the classical ligand-binding site (site 1)and this induces integrin conformational changes and enhancedligand binding to site 1 (PubMed:18635536, PubMed:25398877).ITGA5:ITGB1 acts as a receptor for fibrillin-1 (FBN1) and mediatesR-G-D-dependent cell adhesion to FBN1 (PubMed:12807887,PubMed:17158881). ITGA5:ITGB1 is a receptor for IL1B and bindingis essential for IL1B signaling (PubMed:29030430).{ECO:0000269|PubMed:12807887, ECO:0000269|PubMed:17158881,ECO:0000269|PubMed:18635536, ECO:0000269|PubMed:25398877,ECO:0000269|PubMed:29030430}. (Microbial infection) Integrin ITGA5:ITGB1 acts as areceptor for Human metapneumovirus. {ECO:0000269|PubMed:12907437}. (Microbial infection) Integrin ITGA2:ITGB1 acts as areceptor for Human parvovirus B19. {ECO:0000269|PubMed:24478423}. (Microbial infection) In case of HIV-1 infection, theinteraction with extracellular viral Tat protein seems to enhanceangiogenesis in Kaposi's sarcoma lesions.{ECO:0000269|PubMed:10397733}. | May play an essential role in local proteolysis of theextracellular matrix and in leukocyte migration. Could play a rolein bone osteoclastic resorption. Cleaves KiSS1 at a Gly-|-Leubond. Cleaves type IV and type V collagen into large C-terminalthree quarter fragments and shorter N-terminal one quarterfragments. Degrades fibronectin but not laminin or Pz-peptide.{ECO:0000269|PubMed:1480034}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ITGA5 | chr12:54805618 | chr20:44642763 | ENST00000293379 | - | 2 | 30 | 43_108 | 116 | 1050 | Repeat | FG-GAP 1 |
Tgene | >MMP9 | chr12:54805618 | chr20:44642763 | ENST00000372330 | + | 9 | 13 | 610_657 | 583 | 708 | Repeat | Note=Hemopexin 3 |
Tgene | >MMP9 | chr12:54805618 | chr20:44642763 | ENST00000372330 | + | 9 | 13 | 658_704 | 583 | 708 | Repeat | Note=Hemopexin 4 |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | >ITGA5 | chr12:54805618 | chr20:44642763 | ENST00000293379 | - | 2 | 30 | 280_288 | 116 | 1050 | Calcium binding | . |
Hgene | >ITGA5 | chr12:54805618 | chr20:44642763 | ENST00000293379 | - | 2 | 30 | 334_342 | 116 | 1050 | Calcium binding | . |
Hgene | >ITGA5 | chr12:54805618 | chr20:44642763 | ENST00000293379 | - | 2 | 30 | 401_409 | 116 | 1050 | Calcium binding | . |
Hgene | >ITGA5 | chr12:54805618 | chr20:44642763 | ENST00000293379 | - | 2 | 30 | 465_473 | 116 | 1050 | Calcium binding | . |
Hgene | >ITGA5 | chr12:54805618 | chr20:44642763 | ENST00000293379 | - | 2 | 30 | 1024_1028 | 116 | 1050 | Motif | Note=GFFKR motif |
Hgene | >ITGA5 | chr12:54805618 | chr20:44642763 | ENST00000293379 | - | 2 | 30 | 128_188 | 116 | 1050 | Repeat | FG-GAP 2 |
Hgene | >ITGA5 | chr12:54805618 | chr20:44642763 | ENST00000293379 | - | 2 | 30 | 192_245 | 116 | 1050 | Repeat | FG-GAP 3 |
Hgene | >ITGA5 | chr12:54805618 | chr20:44642763 | ENST00000293379 | - | 2 | 30 | 259_311 | 116 | 1050 | Repeat | FG-GAP 4 |
Hgene | >ITGA5 | chr12:54805618 | chr20:44642763 | ENST00000293379 | - | 2 | 30 | 312_377 | 116 | 1050 | Repeat | FG-GAP 5 |
Hgene | >ITGA5 | chr12:54805618 | chr20:44642763 | ENST00000293379 | - | 2 | 30 | 378_437 | 116 | 1050 | Repeat | FG-GAP 6 |
Hgene | >ITGA5 | chr12:54805618 | chr20:44642763 | ENST00000293379 | - | 2 | 30 | 441_504 | 116 | 1050 | Repeat | FG-GAP 7 |
Hgene | >ITGA5 | chr12:54805618 | chr20:44642763 | ENST00000293379 | - | 2 | 30 | 1022_1049 | 116 | 1050 | Topological domain | Cytoplasmic |
Hgene | >ITGA5 | chr12:54805618 | chr20:44642763 | ENST00000293379 | - | 2 | 30 | 42_995 | 116 | 1050 | Topological domain | Extracellular |
Hgene | >ITGA5 | chr12:54805618 | chr20:44642763 | ENST00000293379 | - | 2 | 30 | 996_1021 | 116 | 1050 | Transmembrane | Helical |
Tgene | MMP9 | chr12:54805618 | chr20:44642763 | ENST00000372330 | + | 9 | 13 | 225_273 | 583 | 708 | Domain | Fibronectin type-II 1 |
Tgene | MMP9 | chr12:54805618 | chr20:44642763 | ENST00000372330 | + | 9 | 13 | 283_331 | 583 | 708 | Domain | Fibronectin type-II 2 |
Tgene | MMP9 | chr12:54805618 | chr20:44642763 | ENST00000372330 | + | 9 | 13 | 342_390 | 583 | 708 | Domain | Fibronectin type-II 3 |
Tgene | MMP9 | chr12:54805618 | chr20:44642763 | ENST00000372330 | + | 9 | 13 | 97_104 | 583 | 708 | Motif | Cysteine switch |
Tgene | MMP9 | chr12:54805618 | chr20:44642763 | ENST00000372330 | + | 9 | 13 | 518_563 | 583 | 708 | Repeat | Note=Hemopexin 1 |
Tgene | MMP9 | chr12:54805618 | chr20:44642763 | ENST00000372330 | + | 9 | 13 | 564_608 | 583 | 708 | Repeat | Note=Hemopexin 2 |
Top |
FusionGeneSequence for ITGA5_MMP9 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
>In-frame_ITGA5_ENST00000293379_chr12_54805618_-_MMP9_ENST00000372330_chr20_44642763_+_241aa MGSRTPESPLHAVQLRWGPRRRPPLLPLLLLLLPPPPRVGGFNLDAEAPAVLSGPPGSFFGFSVEFYRPGTDGVSVLVGAPKANTSQPGV LQGGAVYLCPWGASPTQCTPIEFDSKGRQVWVYTGASVLGPRRLDKLGLGADVAQVTGALRSGRGKMLLFSGRRLWRFDVKAQMVDPRSA |
* Fusion transcript sequences (only coding sequence (CDS) region). |
>In-frame_ITGA5_ENST00000293379_chr12_54805618_-_MMP9_ENST00000372330_chr20_44642763_+_723nt ATGGGGAGCCGGACGCCAGAGTCCCCTCTCCACGCCGTGCAGCTGCGCTGGGGCCCCCGGCGCCGACCCCCGCTGCTGCCGCTGCTGTTG CTGCTGCTGCCGCCGCCACCCAGGGTCGGGGGCTTCAACTTAGACGCGGAGGCCCCAGCAGTACTCTCGGGGCCCCCGGGCTCCTTCTTC GGATTCTCAGTGGAGTTTTACCGGCCGGGAACAGACGGGGTCAGTGTGCTGGTGGGAGCACCCAAGGCTAATACCAGCCAGCCAGGAGTG CTGCAGGGTGGTGCTGTCTACCTCTGTCCTTGGGGTGCCAGCCCCACACAGTGCACCCCCATTGAATTTGACAGCAAAGGGCGCCAGGTG TGGGTGTACACAGGCGCGTCGGTGCTGGGCCCGAGGCGTCTGGACAAGCTGGGCCTGGGAGCCGACGTGGCCCAGGTGACCGGGGCCCTC CGGAGTGGCAGGGGGAAGATGCTGCTGTTCAGCGGGCGGCGCCTCTGGAGGTTCGACGTGAAGGCGCAGATGGTGGATCCCCGGAGCGCC AGCGAGGTGGACCGGATGTTCCCCGGGGTGCCTTTGGACACGCACGACGTCTTCCAGTACCGAGAGAAAGCCTATTTCTGCCAGGACCGC TTCTACTGGCGCGTGAGTTCCCGGAGTGAGTTGAACCAGGTGGACCAAGTGGGCTACGTGACCTATGACATCCTGCAGTGCCCTGAGGAC |
* Fusion transcript sequences (Full-length transcript). |
>In-frame_ITGA5_ENST00000293379_chr12_54805618_-_MMP9_ENST00000372330_chr20_44642763_+_1178nt AGTCCAGACAACCGGCTTCCAGCTGGGGCTGGGGAAAGGGGGTTGGAGGGGTGCGCCCCCCCCCCACGCCCCTTAGGGGTGGGGGACGCG GGCTCAGAGTTCCAGGGACCCAGGAATGCCCCCCCGCCAGCCCCCTCGGCAGGCGGGGGGAGGGCTCAGCCGGGAGTTTGGCAAACTCCT CCCCGCGTTGAGTCATTCGCCTCTGGGAGGTTTAGGAAGCGGCTCCGGGTCGGTGGCCCCAGGACAGGGAAGAGCGGGCGCTATGGGGAG CCGGACGCCAGAGTCCCCTCTCCACGCCGTGCAGCTGCGCTGGGGCCCCCGGCGCCGACCCCCGCTGCTGCCGCTGCTGTTGCTGCTGCT GCCGCCGCCACCCAGGGTCGGGGGCTTCAACTTAGACGCGGAGGCCCCAGCAGTACTCTCGGGGCCCCCGGGCTCCTTCTTCGGATTCTC AGTGGAGTTTTACCGGCCGGGAACAGACGGGGTCAGTGTGCTGGTGGGAGCACCCAAGGCTAATACCAGCCAGCCAGGAGTGCTGCAGGG TGGTGCTGTCTACCTCTGTCCTTGGGGTGCCAGCCCCACACAGTGCACCCCCATTGAATTTGACAGCAAAGGGCGCCAGGTGTGGGTGTA CACAGGCGCGTCGGTGCTGGGCCCGAGGCGTCTGGACAAGCTGGGCCTGGGAGCCGACGTGGCCCAGGTGACCGGGGCCCTCCGGAGTGG CAGGGGGAAGATGCTGCTGTTCAGCGGGCGGCGCCTCTGGAGGTTCGACGTGAAGGCGCAGATGGTGGATCCCCGGAGCGCCAGCGAGGT GGACCGGATGTTCCCCGGGGTGCCTTTGGACACGCACGACGTCTTCCAGTACCGAGAGAAAGCCTATTTCTGCCAGGACCGCTTCTACTG GCGCGTGAGTTCCCGGAGTGAGTTGAACCAGGTGGACCAAGTGGGCTACGTGACCTATGACATCCTGCAGTGCCCTGAGGACTAGGGCTC CCGTCCTGCTTTGGCAGTGCCATGTAAATCCCCACTGGGACCAACCCTGGGGAAGGAGCCAGTTTGCCGGATACAAACTGGTATTCTGTT CTGGAGGAAAGGGAGGAGTGGAGGTGGGCTGGGCCCTCTCTTCTCACCTTTGTTTTTTGTTGGAGTGTTTCTAATAAACTTGGATTCTCT |
Top |
FusionGenePPI for ITGA5_MMP9 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
ITGA5 | ILK, AUP1, CD9, GIPC1, L1CAM, FN1, RABIF, FGFR2, CBL, UBC, ITGB1, SHARPIN, FUBP1, EWSR1, HNRNPU, GRK6, STAMBP, FBXO6, SEL1L, ITGB5, ITGB3, LGALS8, ATP1A1, ATP1B3, LGALS3BP, CLK1, UBAP1, ANGPT2, CTDSPL, BTNL3, FAM19A4, ADAM32, CIB1 | MMP9 | CXCL5, CXCL6, TGFB1, THBS1, THBS2, CLU, COL12A1, TIMP1, COL2A1, COL14A1, COL5A1, COL6A2, COL4A1, FN1, COL4A2, COL6A1, COL18A1, SCARA3 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Hgene | ITGA5 | chr12:54805618 | chr20:44642763 | ENST00000293379 | - | 2 | 30 | 1021_1028 | 116 | 1050 | HPS5 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for ITGA5_MMP9 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Tgene | MMP9 | P14780 | DB01197 | Captopril | Matrix metalloproteinase-9 | small molecule | approved |
Tgene | MMP9 | P14780 | DB01017 | Minocycline | Matrix metalloproteinase-9 | small molecule | approved|investigational |
Tgene | MMP9 | P14780 | DB01296 | Glucosamine | Matrix metalloproteinase-9 | small molecule | approved|investigational |
Tgene | MMP9 | P14780 | DB01593 | Zinc | Matrix metalloproteinase-9 | small molecule | approved|investigational |
Tgene | MMP9 | P14780 | DB00143 | Glutathione | Matrix metalloproteinase-9 | small molecule | approved|investigational|nutraceutical |
Top |
RelatedDiseases for ITGA5_MMP9 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | ITGA5 | C0007137 | Squamous cell carcinoma | 1 | CTD_human |
Hgene | ITGA5 | C0017639 | Gliosis | 1 | CTD_human |
Hgene | ITGA5 | C0027626 | Neoplasm Invasiveness | 1 | CTD_human |
Hgene | ITGA5 | C0035126 | Reperfusion Injury | 1 | CTD_human |
Hgene | ITGA5 | C0038356 | Stomach Neoplasms | 1 | CTD_human |
Tgene | MMP9 | C0027626 | Neoplasm Invasiveness | 7 | CTD_human |
Tgene | MMP9 | C0027627 | Neoplasm Metastasis | 5 | CTD_human |
Tgene | MMP9 | C2937358 | Cerebral Hemorrhage | 5 | CTD_human |
Tgene | MMP9 | C0001973 | Alcoholic Intoxication, Chronic | 3 | PSYGENET |
Tgene | MMP9 | C0007621 | Neoplastic Cell Transformation | 3 | CTD_human |
Tgene | MMP9 | C0004096 | Asthma | 2 | CTD_human |
Tgene | MMP9 | C0005586 | Bipolar Disorder | 2 | PSYGENET |
Tgene | MMP9 | C0006663 | Calcinosis | 2 | CTD_human |
Tgene | MMP9 | C0011853 | Diabetes Mellitus, Experimental | 2 | CTD_human |
Tgene | MMP9 | C0021368 | Inflammation | 2 | CTD_human |
Tgene | MMP9 | C0023895 | Liver diseases | 2 | CTD_human |
Tgene | MMP9 | C0027051 | Myocardial Infarction | 2 | CTD_human |
Tgene | MMP9 | C0031099 | Periodontitis | 2 | CTD_human |
Tgene | MMP9 | C0036341 | Schizophrenia | 2 | PSYGENET |
Tgene | MMP9 | C0003486 | Aortic Aneurysm | 1 | CTD_human |
Tgene | MMP9 | C0003493 | Aortic Diseases | 1 | CTD_human |
Tgene | MMP9 | C0003496 | Aortic Rupture | 1 | CTD_human |
Tgene | MMP9 | C0004114 | Astrocytoma | 1 | CTD_human |
Tgene | MMP9 | C0005967 | Bone neoplasms | 1 | CTD_human |
Tgene | MMP9 | C0007131 | Non-Small Cell Lung Carcinoma | 1 | CTD_human |
Tgene | MMP9 | C0007137 | Squamous cell carcinoma | 1 | CTD_human |
Tgene | MMP9 | C0007786 | Brain Ischemia | 1 | CTD_human |
Tgene | MMP9 | C0009324 | Ulcerative Colitis | 1 | CTD_human |
Tgene | MMP9 | C0009375 | Colonic Neoplasms | 1 | CTD_human |
Tgene | MMP9 | C0011882 | Diabetic Neuropathies | 1 | CTD_human |
Tgene | MMP9 | C0017636 | Glioblastoma | 1 | CTD_human |
Tgene | MMP9 | C0020507 | Hyperplasia | 1 | CTD_human |
Tgene | MMP9 | C0020538 | Hypertensive disease | 1 | CTD_human |
Tgene | MMP9 | C0023176 | Lead Poisoning | 1 | CTD_human |
Tgene | MMP9 | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
Tgene | MMP9 | C0024117 | Chronic Obstructive Airway Disease | 1 | CTD_human |
Tgene | MMP9 | C0024143 | Lupus Nephritis | 1 | CTD_human |
Tgene | MMP9 | C0024668 | Mammary Neoplasms, Experimental | 1 | CTD_human |
Tgene | MMP9 | C0024796 | Marfan Syndrome | 1 | CTD_human |
Tgene | MMP9 | C0026552 | Morphine Dependence | 1 | CTD_human |
Tgene | MMP9 | C0026766 | Multiple Organ Failure | 1 | CTD_human |
Tgene | MMP9 | C0028754 | Obesity | 1 | CTD_human |
Tgene | MMP9 | C0029172 | Oral Submucous Fibrosis | 1 | CTD_human |
Tgene | MMP9 | C0030297 | Pancreatic Neoplasm | 1 | CTD_human |
Tgene | MMP9 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
Tgene | MMP9 | C0034067 | Pulmonary Emphysema | 1 | CTD_human |
Tgene | MMP9 | C0034069 | Pulmonary Fibrosis | 1 | CTD_human |
Tgene | MMP9 | C0035126 | Reperfusion Injury | 1 | CTD_human |
Tgene | MMP9 | C0035309 | Retinal Diseases | 1 | CTD_human |
Tgene | MMP9 | C0037286 | Skin Neoplasms | 1 | CTD_human |
Tgene | MMP9 | C0038358 | Gastric ulcer | 1 | CTD_human |
Tgene | MMP9 | C0038587 | Substance Withdrawal Syndrome | 1 | CTD_human |
Tgene | MMP9 | C0086132 | Depressive Symptoms | 1 | PSYGENET |
Tgene | MMP9 | C0151526 | Premature Birth | 1 | CTD_human |
Tgene | MMP9 | C0162871 | Aortic Aneurysm, Abdominal | 1 | CTD_human |
Tgene | MMP9 | C0162872 | Aortic Aneurysm, Thoracic | 1 | CTD_human |
Tgene | MMP9 | C0243026 | Sepsis | 1 | CTD_human |
Tgene | MMP9 | C0338831 | Manic | 1 | PSYGENET |
Tgene | MMP9 | C0340288 | Stable angina | 1 | CTD_human |
Tgene | MMP9 | C0432291 | Mandibuloacral dysostosis | 1 | CTD_human |
Tgene | MMP9 | C0740392 | Infarction, Middle Cerebral Artery | 1 | CTD_human |
Tgene | MMP9 | C0948089 | Acute Coronary Syndrome | 1 | CTD_human |
Tgene | MMP9 | C1458155 | Mammary Neoplasms | 1 | CTD_human |
Tgene | MMP9 | C1527311 | Brain Edema | 1 | CTD_human |
Tgene | MMP9 | C2239176 | Liver carcinoma | 1 | CTD_human |
Tgene | MMP9 | C2936380 | Neointima | 1 | CTD_human |